omniture
logo
Search
上海爱科百发生物医药技术股份有限公司
Media Room

Latest News

rss

Ark Biopharmaceutical Receives IND Approval from NMPA for AK0610, a Respiratory Syncytial Virus Neutralizing Antibody

SHANGHAI, Nov. 23, 2023 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announces...

2023-11-23 08:00 1993

Ark Biopharmaceutical and Calibr, a Division of Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad Spectrum of Respiratory Diseases, Including COPD

* Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating c...

2023-03-16 07:50 2988